Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

CJC-1295 (without DAC) and Exemestane Interaction: Synergistic | Peptide Database

Can you take CJC-1295 (without DAC) with Exemestane? Synergistic interaction (60% confidence). See pharmacological analysis, organ load, safety flags, and dosing guidance.

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

Compound Profiles

CJC-1295 (without DAC)

Short-Acting Growth Hormone Releasing Hormone Analog

Binds GHRH receptors on somatotroph cells in the pituitary gland, stimulating cAMP production and physiological GH pulses. The brief 30-minute half-life allows pulsatile release versus prolonged elevation.

Exemestane

Steroidal Aromatase Inhibitor | Irreversible Estrogen Control

Exemestane functions as a mechanism-based (suicide) inhibitor of aromatase (cytochrome P450 19A1). Due to its steroidal structure, exemestane is recognized by aromatase as a substrate analogue and enters the enzyme's active site.

Combined Organ Load

Shared Safety Flags

Frequently Asked Questions

Can I take CJC-1295 (without DAC) with Exemestane?

Yes, CJC-1295 (without DAC) and Exemestane can generally be taken together. Exemestane helps manage estrogen conversion from CJC-1295 (without DAC). This is a common and recommended combination. Adjust AI dose based on bloodwork — avoid crashing estrogen.

Is CJC-1295 (without DAC) and Exemestane safe together?

Based on pharmacological analysis, this combination is considered synergistic. However, shared safety flags include: estrogenic, teratogenic. Monitor accordingly.

What are the interactions between CJC-1295 (without DAC) and Exemestane?

Exemestane helps manage estrogen conversion from CJC-1295 (without DAC). This is a common and recommended combination. Adjust AI dose based on bloodwork — avoid crashing estrogen. This assessment has 60% confidence and is inferred from pharmacological mechanism analysis.

How should I time CJC-1295 (without DAC) and Exemestane?

CJC-1295 (without DAC) has a half-life of 30 minutes - 2 hours and Exemestane has a half-life of ~24 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.

Connected topics

Follow this recovery question